Yahoo Web Search

Search results

1. • 

     Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?

     Investor's Business Daily· 24 hours ago

     Prevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...

2. • 

     Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

     Motley Fool via Yahoo Finance· 2 days ago

     It aims to develop or acquire lower-risk, less splashy drugs it knows it can market. Underscoring...

3. • Mutual of America Capital Management LLC Cuts Position in Biogen Inc. (NASDAQ:BIIB)

     ETF DAILY NEWS· 6 days ago

     Mutual of America Capital Management LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.3% in the 4th quarter, according to the company in its most recent 13F filing with ...

4. • 

     Are your prescription drugs affordable? Colorado board wants feedback on these 2

     KDVR Denver via Yahoo News· 2 days ago

     The body was created in 2021 to review prescription drugs and evaluate their affordability for...

5. • Wedbush Lowers Biogen (NASDAQ:BIIB) Price Target to $213.00

     ETF DAILY NEWS· 12 hours ago

     Biogen (NASDAQ:BIIB – Get Free Report) had its price target decreased by equities research analysts at Wedbush from $245.00 to $213.00 in a research report issued to clients and investors on ...

6. • TD Cowen Lowers Amgen (NASDAQ:AMGN) Price Target to $360.00

     ETF DAILY NEWS· 11 hours ago

     Amgen (NASDAQ:AMGN – Get Free Report) had its price target dropped by TD Cowen from $370.00 to $360.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a ...

7. • Biogen (NASDAQ:BIIB) Price Target Cut to $214.00

     ETF DAILY NEWS· 12 hours ago

     Biogen (NASDAQ:BIIB – Get Free Report) had its price target reduced by equities research analysts at UBS Group from $250.00 to $214.00 in a research note issued on Wednesday, Benzinga reports ...

8. • Looking At Amgen's Recent Unusual Options Activity - Amgen (NASDAQ:AMGN)

     Benzinga· 7 days ago

     Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced ...

9. • Biogen Inc. (NASDAQ:BIIB) Short Interest Update

     ETF DAILY NEWS· 5 days ago

     Biogen Inc. (NASDAQ:BIIB – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 3,550,000 ...

10. • Clarius Group LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB)

      ETF DAILY NEWS· 4 days ago

      Clarius Group LLC boosted its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The ...